Target intelligence / Profile preview

RNA, U2 small nuclear 48, pseudogene (RNU2-48P)

Target
RNU2-48P
Molecular classification
Other
01

Overview

RNU2-48P (RNA, U2 small nuclear 48, pseudogene) is a pseudogene in the human genome that is homologous to genes coding for U2 small nuclear RNA (snRNA), a critical component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotic cells. As a pseudogene, RNU2-48P does not produce a functional protein or RNA product and does not play a direct, characterized biological role in humans. Pseudogenes like RNU2-48P typically arise from duplication or retrotransposition events and have lost their original function due to mutations or lack of regulatory elements. The precise NCBI Gene ID for RNU2-48P is 106481649. There are no established alternative names in major databases. As a pseudogene, this locus is not transcribed into a functional U2 snRNA, and there is no evidence it is involved in any active cellular process. Since pseudogenes lack an active biological function, RNU2-48P is not considered a therapeutic target, biomarker, or druggable molecule. The U2 small nuclear RNA family includes active components (U2 snRNAs, e.g., RNU2-1, RNU2-2) essential for spliceosome function, but RNU2-48P itself is non-functional. This gene symbol represents a non-functional, non-protein-coding pseudogene, making it an incorrect or uninformative entry for therapeutic target lists. In summary, RNU2-48P is a pseudogene and is not a biologically active target or relevant for therapeutic intervention.

Other names
RNU2-48P

Beyond the preview

Go deeper on RNA, U2 small nuclear 48, pseudogene (RNU2-48P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 48, pseudogene (RNU2-48P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call